Patient-reported outcomes in lung and esophageal cancer

被引:14
|
作者
Hirpara, Dhruviti H. [1 ]
Gupta, Vaibhav [1 ]
Brown, Lisa [2 ,3 ]
Kidane, Biniam [3 ,4 ]
机构
[1] Univ Toronto, Dept Surg, Toronto, ON, Canada
[2] Univ Calif Davis, Dept Surg, Sacramento, CA 95817 USA
[3] Hlth Sci Ctr, Thorac Surg Outcomes Res Network ThORN, Winnipeg, MB, Canada
[4] Hlth Sci Ctr, Sect Thorac Surg, Winnipeg, MB, Canada
关键词
Patient-reported outcome (PRO); health-related quality of life (HRQOL); lung cancer; esophageal cancer; thoracic surgery; QUALITY-OF-LIFE; ASSISTED THORACIC-SURGERY; FUNCTIONAL ASSESSMENT; PROGNOSTIC VALUE; CLINICAL-TRIALS; SURVIVAL; THERAPY; QLQ-C30; SCORES; CHEMORADIOTHERAPY;
D O I
10.21037/jtd.2019.01.02
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Carcinomas of the lung and esophagus are associated with significant disease and treatment related morbidity. Measuring patients' self-perceived notion of their health-related quality of life (HRQOL), throughout the course of illness, is central to the delivery of comprehensive, patient-centered care. This article reviews commonly used HRQOL instruments in thoracic surgery and discusses the integral role of patient-reported outcomes (PROs) in comparative effectiveness research and prognostication in the realm of lung and esophageal cancer. We also highlight challenges and future directions for widespread implementation of PROs into clinical and research practice.
引用
收藏
页码:S509 / S514
页数:6
相关论文
共 50 条
  • [1] Patient-Reported Outcomes in Esophageal Diseases
    Reed, Craig C.
    Dellon, Evan S.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (03) : 305 - 310
  • [2] THE VALUE OF PATIENT-REPORTED OUTCOMES IN LUNG CANCER CLINICAL
    Pompili, Cecilia
    Feldman, Jill
    JTCVS OPEN, 2022, 12 : 426 - 427
  • [3] Patient-Reported Outcomes After Treatment for Lung Cancer
    Hill-Kayser, C. E.
    Vachani, C.
    Hampshire, M. K.
    Di Lullo, G. A.
    Metz, J. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S117 - S118
  • [4] Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery
    Dhanasopon, Andrew P.
    Boffa, Daniel J.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (09) : 5367 - 5368
  • [5] Defining Relevancy in Patient-Reported Outcomes for Lung Cancer Surgery
    Andrew P. Dhanasopon
    Daniel J. Boffa
    Annals of Surgical Oncology, 2022, 29 : 5367 - 5368
  • [6] Patient-reported outcomes in lung cancer surgery: A narrative review
    Yi, Hang
    Xu, Ou-Yang
    Hong, Qian
    Liu, Lu
    Liu, Man
    Wang, Yan
    Zhang, Guochao
    Ma, Fengyan
    Mu, Juwei
    Mao, Yousheng
    ASIAN JOURNAL OF SURGERY, 2025, 48 (01) : 40 - 48
  • [7] The State of the Science in Patient-Reported Outcomes for Patients with Lung Cancer
    Xiao, Canhua
    Hurst, Newton
    Movsas, Benjamin
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 377 - 385
  • [8] Implementation of a methodology to assess patient reported outcomes in lung cancer patients: The PeOpLe (Patient-reported Outcomes in Lung cancer) study protocol
    Villanueva-Bueno, Cristina
    Collado-Borrell, Roberto
    Luis Revuelta-Herrero, Jose
    Beatriz Fernandez-Roman, Ana
    Casado-Abad, Gema
    Escudero-Vilaplana, Vicente
    FARMACIA HOSPITALARIA, 2022, 46 (04) : 265 - 269
  • [9] Pilot Study of Patient-Reported Outcomes in Patients With Esophageal Cancer After Esophagectomy
    Heiden, Brendan T.
    Subramanian, Melanie P.
    Liu, Jingxia
    Keith, Angela
    Engelhardt, Kathryn E.
    Meyers, Bryan F.
    Puri, Varun
    Kozower, Benjamin D.
    ANNALS OF THORACIC SURGERY, 2022, 114 (04): : 1135 - 1141
  • [10] Advantages of using patient-reported outcomes (PROs) during chemotherapy for esophageal cancer
    Sakakida, Tomoki
    Ishikawa, Takeshi
    Doi, Toshifumi
    Morita, Ryuichi
    Inoue, Ken
    Harusato, Akito
    Dohi, Osamu
    Yoshida, Naohisa
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Konishi, Hideyuki
    Itoh, Yoshito
    ANNALS OF ONCOLOGY, 2022, 33 : S539 - S539